SCHEMBL26340003

SCHEMBL26340003

Nc1ccc(C(=O)O[C@@H]2CCCC(c3ccccc3Cl)C2=O)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ POLB P06746 1/20 0.37
▸ ALOX15 P16050 1/20 0.35
▸ PPID Q08752 1/20 0.35
▸ PPIG Q13427 1/20 0.35
▸ FABP5 Q01469 1/20 0.35
▸ RXFP1 Q9HBX9 1/20 0.35
▸ GLA P06280 2/20 0.34
▸ GAA P10253 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ CASP1 P29466 2/20 0.34
▸ CASP7 P55210 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ HSD11B1 P28845 2/20 0.34
▸ BCHE P06276 1/20 0.34
▸ CDK7 P50613 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26340042 0.85 ALDH1A1 (0.42) KDM4EALDH1A1POLBALOX15RXFP1
SCHEMBL23352415 0.84 MAPT (0.45) KDM4EALDH1A1POLBBCHERAB9A
SCHEMBL19403922 0.84 MAPT (0.45) KDM4EALDH1A1POLBBCHERAB9A
SCHEMBL25771258 0.74 TP53 (0.39) KDM4EALDH1A1ALOX15
SCHEMBL25569236 0.73 ALDH1A1 (0.35) KDM4EALDH1A1POLBPPIDPPIG
SCHEMBL26340378 0.72 ALDH1A1 (0.42) KDM4EALDH1A1GAAHPGDNPC1
SCHEMBL26340737 0.70 ALDH1A1 (0.41) KDM4EALDH1A1POLBGAAHPGD
SCHEMBL14866651 0.70 TP53 (0.41) ALDH1A1POLBALOX15GAAL3MBTL1
SCHEMBL23471602 0.70 TP53 (0.41) ALDH1A1POLBALOX15GAAL3MBTL1
SCHEMBL20993884 0.70 TP53 (0.41) ALDH1A1POLBALOX15GAAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303481-A1 LONG-ACTING LOW-ADDICTION HNK DERIVATIVE AND PREPARATION METHOD THEREFOR SHENZHEN RUIJIAN BIOTECHNOLOGY CO., LTD (CN) 2023-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303481-A1 LONG-ACTING LOW-ADDICTION HNK DERIVATIVE AND PREPARATION METHOD THEREFOR OPRK1, OPRL1, NTRK1 KDM4E 3375/4885ALDH1A1 3380/4885POLB 1819/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback